Skip to main content
Urgent hypertension as a biomarker for bevacizumab in the curative setting. Kassem, N., Shen, F., Jiang, G., Gardner, L., Philips, S., O'Neill, A. M., Miller, K. D., Suter, T., Cameron, D. A., Sledge, G. W., Schneider, B. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.548

View details for Web of Science ID 000442916000057